This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.90% per year. These returns cover a period from January 1, 1988 through December 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
RMD Stock Set to Gain From FDA Clearance of AI-Enabled Smart Comfort
by Zacks Equity Research
Resmed gains FDA's nod for Smart Comfort, an AI-driven CPAP tool boosting sleep therapy personalization and adherence.
OMCLPositive Net Change ILMNPositive Net Change RMDPositive Net Change BTSGPositive Net Change
medical medical-devices
CONMED Stock Falls as It Strategically Exits Gastroenterology Portfolio
by Zacks Equity Research
CNMD is set to exit its gastroenterology portfolio to streamline its focus on higher-growth surgical platforms and boost long-term margins.
BSXNegative Net Change CNMDPositive Net Change ISRGNegative Net Change MEDPPositive Net Change
medical medical-devices
Tempus AI: Data Flywheel and MRD Expansion Reshape the Outlook
by Urmimala Biswas
Tempus AI's data engine, MRD buildout and ADLT milestones set the stage for faster growth while profitability metrics turn the corner.
ILMNPositive Net Change GHNegative Net Change TEMPositive Net Change
artificial-intelligence earnings-report healthcare medical medical-devices
The Pennant Group, Inc. (PNTG) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
PNTGPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
HOLX Stock Up 16% in 6 Months: Is it Still a Hold Heading Into 2026?
by Moumi Mondal
Hologic shares rise 16% in six months, with divisional strength clinical data and a go-private deal shaping the short-term outlook.
ABTNegative Net Change HOLXNegative Net Change QGENNegative Net Change
medical medical-devices
ISRG Stock Forms Golden Crossover: Will the Uptrend Continue?
by Indrajit Bandyopadhyay
Intuitive Surgical's golden crossover arrives amid surging procedures and rapid dV5 adoption, raising the stakes for its bullish momentum.
MDTNegative Net Change SYKNegative Net Change ISRGNegative Net Change
medical medical-devices
BD Stock Up Post Tie-Up to Expand Hazardous Drug Contamination Testing
by Zacks Equity Research
BDX teams up with ChemoGLO to expand hazardous drug testing, aiming to boost safety in healthcare environments.
BDXNo Net Change ISRGNegative Net Change CAHPositive Net Change SOLVNegative Net Change
medical medical-devices
GEHC Forms 7-Year Care Alliance to Advance URMC Imaging & Monitoring
by Zacks Equity Research
GE HealthCare's seven-year alliance with URMC advances imaging, precision medicine and system-wide monitoring upgrades across UR Medicine.
BSXNegative Net Change ISRGNegative Net Change MEDPPositive Net Change GEHCNegative Net Change
medical medical-devices
ATN International (ATNI) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
ATNIPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Transportadora De Gas Sa Ord B (TGS) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
TGSNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Si-Bone (SIBN) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
SIBNNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Tempus AI: Revenue Mix and 2026 Growth Outlook Explained
by Urmimala Biswas
Tempus AI's balanced genomics and data engine is scaling fast as profitability metrics improve and 2026 revenue targets approach the billion-plus mark.
EXASPositive Net Change GHNegative Net Change TEMPositive Net Change
healthcare medical medical-devices oncology-screening
COO Gains as Q4 Earnings & Sales Beat Estimates, MyDay Adoption Rises
by Zacks Equity Research
COO jumps after Q4 earnings and sales top estimates, powered by rising MyDay demand and strong MiSight momentum.
ISRGNegative Net Change COONegative Net Change MEDPPositive Net Change SGHTPositive Net Change
earnings medical medical-devices
Here's Why You Should Add Inogen Stock to Your Portfolio Now
by Zacks Equity Research
INGN gains momentum from rising POC demand, new product launches and strong Q3 sales, even as competition and forex swings temper near-term growth.
ISRGNegative Net Change INGNNegative Net Change MEDPPositive Net Change SGHTPositive Net Change
medical medical-devices
MDT Stock Set to Benefit From the FDA Clearance of Hugo RAS System
by Zacks Equity Research
Medtronic gains from the FDA clearance of its Hugo RAS system, expanding U.S. access to robotic-assisted urologic surgery.
MDTNegative Net Change OMCLPositive Net Change ILMNPositive Net Change BTSGPositive Net Change
medical medical-devices
HIMS Stock Jumps After Buyout Deal, Boosts Blood Collection Efficiency
by Zacks Equity Research
Hims & Hers is set to acquire YourBio Health, adding bladeless microneedle tech to transform the blood collection experience.
ISRGNegative Net Change IDXXPositive Net Change HIMSPositive Net Change SOLVNegative Net Change
medical medical-devices
HealthEquity Stock Gains as Q3 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
HQY stock gains post Q3 results as earnings and revenue top estimates, supported by rising HSAs and stronger margins.
BSXNegative Net Change ISRGNegative Net Change HQYNegative Net Change MEDPPositive Net Change
earnings medical medical-devices
GEHC and Mayo Clinic Launch GEMINI-RT to Aid Personalized Cancer Care
by Zacks Equity Research
GE HealthCare and Mayo Clinic unveil GEMINI-RT, which is likely to blend imaging, AI and monitoring to advance personalized cancer care.
BSXNegative Net Change ISRGNegative Net Change MEDPPositive Net Change GEHCNegative Net Change
medical medical-devices
Hologic's BCI Test Shows Growing Impact in Endocrine Therapy Decisions
by Moumi Mondal
HOLX's BCI test gains traction as new SABCS studies are set to highlight its growing role in guiding extended endocrine therapy decisions.
BDXNo Net Change MDTNegative Net Change HOLXNegative Net Change
medical medical-devices
Here's Why You Should Add CONMED Stock to Your Portfolio Now
by Zacks Equity Research
CONMED gains momentum from high-margin platforms and supply-chain recovery, even as tariffs and dV5 adoption weigh on near-term margins.
CNMDPositive Net Change ISRGNegative Net Change IDXXPositive Net Change PODDNegative Net Change
medical medical-devices
Margins Face Tariff Pressure: Is ISRG's Profitability at Risk?
by Indrajit Bandyopadhyay
Intuitive Surgical's strong growth contrasts with tariff-driven margin pressure, raising questions about its ability to hold gross margins near 67%.
MDTNegative Net Change SYKNegative Net Change ISRGNegative Net Change
medical medical-devices
Cooper Companies to Post Q4 Earnings: What's in Store for the Stock?
by Zacks Equity Research
COO is set to post Q4 earnings as MyDAY momentum offsets Clariti and APAC softness, with revenues and earnings expected to rise.
EWNegative Net Change HOLXNegative Net Change DXCMPositive Net Change COONegative Net Change
medical medical-devices
Hims & Hers Expands Care Scope as Prescription Platforms Evolve
by Debanjana Dey
HIMS grows its telehealth-to-prescription model with new offerings in weight loss, hormone care and diagnostics.
AMWLNegative Net Change HIMSPositive Net Change LFMDPositive Net Change
medical medical-devices
After Golden Cross, Assured Guaranty (AGO)'s Technical Outlook is Bright
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
AGONegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Continue to Hold RMD Stock in Your Portfolio?
by Zacks Equity Research
Resmed sees strong mask sales, strategic acquisitions and international expansion despite macro and competitive challenges.
BSXNegative Net Change MDTNegative Net Change RMDPositive Net Change GMEDNegative Net Change
medical medical-devices